From the Guidelines
NAD+ (nicotinamide adenine dinucleotide) does not have adrenergic properties. NAD+ is a coenzyme found in all living cells that functions primarily as an electron carrier in metabolic reactions, particularly in cellular respiration and energy production. Unlike adrenergic compounds, which activate adrenergic receptors and mimic the effects of adrenaline and noradrenaline, NAD+ does not bind to or activate these receptors. NAD+ is involved in redox reactions, serves as a substrate for enzymes like sirtuins that regulate cellular processes including aging and stress responses, and participates in DNA repair mechanisms. Its biological role is fundamentally different from adrenergic compounds, which affect the sympathetic nervous system and trigger "fight or flight" responses. While NAD+ supplementation has gained interest for potential health benefits related to aging and metabolism, these effects occur through metabolic pathways and not through adrenergic receptor activation, as supported by studies on the role of NAD+ in energy metabolism and its potential link to age-related sarcopenia 1.
The provided evidence on vasoactive agents in shock 2 does not support a role for NAD+ in adrenergic responses, as it focuses on the effects of catecholamines like norepinephrine and epinephrine on cardiac function and blood pressure. In contrast, NAD+ is discussed in the context of its role in energy metabolism and as a cofactor for enzymes involved in DNA repair and cellular regulation 1.
Key points to consider:
- NAD+ is a coenzyme involved in metabolic reactions, not adrenergic responses
- Adrenergic compounds activate adrenergic receptors, which is not a function of NAD+
- NAD+ supplementation may have health benefits related to aging and metabolism, but these effects are not mediated through adrenergic receptor activation
- The biological role of NAD+ is distinct from that of adrenergic compounds, which affect the sympathetic nervous system.